• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Attuning Percutaneous Coronary Interventional Quality Metrics and Practice Modification.

作者信息

Klein Lloyd W

机构信息

Cardiology Division, University of California, San Francisco, California, USA.

出版信息

JACC Asia. 2024 Feb 20;4(4):332-334. doi: 10.1016/j.jacasi.2024.01.003. eCollection 2024 Apr.

DOI:10.1016/j.jacasi.2024.01.003
PMID:38660109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11035927/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/11035927/2028417d4f51/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/11035927/2028417d4f51/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d38/11035927/2028417d4f51/ga1.jpg

相似文献

1
Attuning Percutaneous Coronary Interventional Quality Metrics and Practice Modification.协调经皮冠状动脉介入治疗的质量指标与实践改进。
JACC Asia. 2024 Feb 20;4(4):332-334. doi: 10.1016/j.jacasi.2024.01.003. eCollection 2024 Apr.
2
Interventional cardiologists' perceptions of percutaneous coronary intervention quality measurement and feedback.介入心脏病学家对经皮冠状动脉介入治疗质量测量和反馈的看法。
Am Heart J. 2021 May;235:97-103. doi: 10.1016/j.ahj.2021.01.019. Epub 2021 Feb 7.
3
Benchmarking System Monitoring on Quality Improvement in Percutaneous Coronary Intervention: A Nationwide Registry in Japan.经皮冠状动脉介入治疗质量改进的基准系统监测：日本全国性注册研究
JACC Asia. 2024 Feb 20;4(4):323-331. doi: 10.1016/j.jacasi.2023.12.003. eCollection 2024 Apr.
4
Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning.机器学习在临床风险预测模型比较分析中的性能指标
Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e007526. doi: 10.1161/CIRCOUTCOMES.120.007526. Epub 2021 Oct 4.
5
Assessment of individual operator performance using a risk-adjustment model for percutaneous coronary interventions.使用经风险调整模型评估经皮冠状动脉介入治疗术的个体术者操作表现。
Mayo Clin Proc. 2013 Nov;88(11):1250-8. doi: 10.1016/j.mayocp.2013.07.017.
6
Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists.纽约州介入心脏病学家的经皮冠状动脉介入治疗后 30 天死亡率与教育和认证变量之间的关联。
Circ Cardiovasc Interv. 2018 Sep;11(9):e006094. doi: 10.1161/CIRCINTERVENTIONS.117.006094.
7
Early Post-Percutaneous Coronary Intervention Chest Pain: A Nationwide Survey on Interventional Cardiologists' Perspective.经皮冠状动脉介入治疗术后胸痛的早期：介入心脏病学家观点的全国性调查。
Cardiovasc Revasc Med. 2020 Dec;21(12):1517-1522. doi: 10.1016/j.carrev.2020.05.011. Epub 2020 May 16.
8
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease.多支冠状动脉疾病患者治疗中心脏团队与介入心脏病专家推荐的比较。
JAMA Netw Open. 2020 Aug 3;3(8):e2012749. doi: 10.1001/jamanetworkopen.2020.12749.
9
Quality improvement in chronic care by self-audit, benchmarking and networking in general practices in South Tyrol, Italy: results from an interventional study.意大利南蒂罗尔地区全科医疗中通过自我审核、基准比对和网络建设实现慢性病护理质量改进：一项干预性研究的结果
Fam Pract. 2021 Jun 17;38(3):253-258. doi: 10.1093/fampra/cmaa123.
10
Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry.通过全国经皮冠状动脉介入治疗结果登记处提高澳大利亚的指南依从性。
Heart Lung Circ. 2017 Dec;26(12):1303-1309. doi: 10.1016/j.hlc.2017.01.008. Epub 2017 Feb 28.

本文引用的文献

1
Benchmarking System Monitoring on Quality Improvement in Percutaneous Coronary Intervention: A Nationwide Registry in Japan.经皮冠状动脉介入治疗质量改进的基准系统监测：日本全国性注册研究
JACC Asia. 2024 Feb 20;4(4):323-331. doi: 10.1016/j.jacasi.2023.12.003. eCollection 2024 Apr.
2
The appropriate use criteria: Improvements for its integration into real world clinical practice.适宜使用标准：为融入现实世界临床实践而进行的改进。
Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1349-1357. doi: 10.1002/ccd.29784. Epub 2021 Jun 3.
3
Overcoming Obstacles in Designing and Sustaining a High-Quality Cardiovascular Procedure Environment.
克服设计和维持高质量心血管手术环境中的障碍。
JACC Cardiovasc Interv. 2020 Dec 14;13(23):2806-2810. doi: 10.1016/j.jcin.2020.06.008. Epub 2020 Oct 14.
4
Performance Metrics to Improve Quality in Contemporary Percutaneous Coronary Intervention Practice.
JAMA Cardiol. 2020 Aug 1;5(8):859-860. doi: 10.1001/jamacardio.2020.0904.
5
Proposed Framework for the Optimal Measurement of Quality Assessment in Percutaneous Coronary Intervention.经皮冠状动脉介入治疗质量评估的最佳测量建议框架。
JAMA Cardiol. 2019 Oct 1;4(10):963-964. doi: 10.1001/jamacardio.2019.3228.
6
Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients.经皮冠状动脉介入治疗后风险调整死亡率的公开报告的影响：对高危患者（包括非手术患者）的误解和潜在后果。
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2077-2085. doi: 10.1016/j.jcin.2016.08.012.
7
Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines.美国心脏病学会/美国心脏协会特别工作组指南中经皮冠状动脉介入治疗的手术指征与结果之间的关系
Circulation. 2005 Nov 1;112(18):2786-91. doi: 10.1161/CIRCULATIONAHA.105.553727.